-nabant
Drugs that block cannabinoid receptors.
- Drugs ending in -nabant: 7
- Approved somewhere: 1
- With a US drug page: 0
- Stem
- -nabant
- Class
- Drugs that block cannabinoid receptors
- Most common targets
- CNR1 (6)
Approved and clinical-stage drugs in ChEMBL whose names ending in -nabant, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Rimonabant | Approved | CNR1 | Cannabinoid CB1 receptor antagonist |
| Otenabant | Phase 3 | CNR1 | Cannabinoid CB1 receptor antagonist |
| Taranabant | Phase 3 | CNR1 | Cannabinoid CB1 receptor inverse agonist |
| Drinabant | Phase 2 | CNR1 | Cannabinoid CB1 receptor antagonist |
| Ibipinabant | Phase 2 | CNR1 | Cannabinoid CB1 receptor antagonist |
| Surinabant | Phase 2 | CNR1 | Cannabinoid CB1 receptor antagonist |
| Selonabant | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO